Home Did You Know? Risky Importation Proposals
Risky Importation Proposals

PhRMA CEO Billy Tauzin
Bloomberg Television
What Government Officials Are Saying About Counterfeit Drugs

Have you ever asked your doctor or pharmacist if your medicine is real or counterfeit?  Probably not – and nor should you have to.  Unfortunately, such questions may become commonplace if Congress passes a bill that would allow for the importation of medicines from foreign countries. 
 
American patients currently enjoy peace of mind knowing that their medicines, for the most part, are safe and effective.  While every drug carries both benefits and risks, patients in the U.S. can generally be confident in the authenticity of their medicines.
 
These assurances are made possible by the closed drug distribution system overseen by the Food and Drug Administration (FDA) and the states – a system that helps to protect the public health.  This closed distribution system, however, could be threatened by the soaring epidemic of counterfeits around the world, if the floodgates are opened by this legislation.  Read More
 



Federal Agencies                     

Leading U.S. government agencies – such as the Food and Drug Administration – have issued numerous warnings to the American public about buying medicines online from foreign sources. Online drug sellers that are operated out of foreign countries and offering American patients what may seem to be a good deal, may be providing substandard and counterfeit medicines. Read more about how government officials are taking steps to protect American patients.

Food and Drug Administration
U.S. Department of Health & Human Services
U.S. Surgeon General

  Congressional & State Activity

Members of Congress and numerous State Legislatures are considering prescription drug importation bills that could potentially allow dangerous counterfeit medicines to enter U.S. borders from foreign countries.  Some policies currently under consideration would allow medicines that are not approved by the Food and Drug Administration and not bio-equivalent to end up on pharmacy shelves across America.

Read More About Congress & State Legislature Activity